Due to the ubiquitous smartphone and other such interconnected devices, interactive food labels have grown in popularity. These labels can help to provide product traceability through the supply chains as well as personalising products for consumers; for example, personalising the product to address consumers’ concerns for nut allergies. But according to a University of Exeter study, regulations now need to catch up with these new innovations to ensure public safety.
The study notes that AI technology could play a significant role in making labelling more comprehensive and personalised, but regulators must ensure the technology is used for public good and not just to collect data about customers, or help manufacturing or distribution.
Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.